Alyeska Investment Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Alyeska Investment Group’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-880,173	Closed	-$16.6M	–	540
2019 Q3	$16.6M	Buy	+880,173	New	+$10.1M	0.24%	127
2018 Q3	–	Sell	-114,528	Closed	-$1.81M	–	567
2018 Q2	$1.81M	Buy	114,528 +53,663	+88%	+$815K	0.02%	359
2018 Q1	$773K	Sell	60,865 -549	-0.9%	-$7.94K	0.01%	404
2017 Q4	$703K	Hold	61,414	–	–	0.01%	398
2017 Q3	$752K	Buy	+61,414	New	+$640K	0.01%	430
2014 Q4	–	Sell	-56,937	Closed	-$722K	–	562
2014 Q3	$722K	Buy	56,937 +18,193	+47%	+$275K	0.01%	347
2014 Q2	$778K	Buy	+38,744	New	+$546K	0.02%	362

Alyeska Investment Group's ALDR Position: Q4 2019 in Review

Alyeska Investment Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 880,173 shares — an estimated $16.6M sold.

Alyeska Investment Group first reported a position in ALDR in Q2 2014 and held it in 7 quarters. The position peaked at $16.6M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Alyeska Investment Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Alyeska Investment Group sold 880,173 Alder Biopharmaceuticals shares in Q4 2019, an estimated $16.6M.
Alyeska Investment Group first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 7 quarters.
Alyeska Investment Group's Alder Biopharmaceuticals position peaked at $16.6M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Alyeska Investment Group's 13F filing for Q4 2019, filed 14 Feb 2020.